Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
220 Leser
Artikel bewerten:
(0)

ICUs in Michigan Sustain Zero Bloodstream Infections for up to 2 Years

ROCKVILLE, Md., May 9, 2011 /PRNewswire-USNewswire/ -- Intensive care units (ICUs) in both large and small hospitals stopped central line-associated bloodstream infections for up to 2 years after using a targeted quality improvement initiative funded in part by the Agency for Healthcare Research and Quality. The initiative, known as the Comprehensive Unit-based Safety Program, or CUSP, was implemented through the Keystone Intensive Care Unit Project in Michigan hospitals.

The study, "The Ability of Intensive Care Units to Maintain Zero Central Line-Associated Bloodstream Infections" published in today's issue of the Archives of Internal Medicine found that hospital ICUs eliminated central line-associated bloodstream infections (CLABSIs) for an extended period of time - up to 2 years or more. The researchers found that 60 percent of the 80 ICUs evaluated went 1 year or more without an infection, and 26 percent achieved 2 years or more. Smaller hospitals sustained zero infections longer than larger hospitals, the researchers found.

"Previous research has shown that using CUSP to reduce healthcare-associated infections works," said AHRQ Director Carolyn M. Clancy, M.D. "This study gives us even better news - that results from efforts to eliminate these deadly and costly infections can be sustained."

A CLABSI is a serious healthcare-associated infection (HAI) that is introduced into the bloodstream through a central line.According to the Centers for Disease Control and Prevention (CDC), at any one point in time one in every 20 hospital patients in the United States has an HAI.

"This study demonstrates that any hospital ICU can go a year or two without an infection if it commits to implementing this targeted quality improvement initiative. With CUSP, the goal of a year or two without a CLABSI is achievable," said the study's lead author, Peter J. Pronovost, M.D., Ph.D., a professor of anesthesiology and critical care medicine at The Johns Hopkins University School of Medicine in Baltimore. In conjunction with the Michigan Health and Hospital Association, Dr. Pronovost led development of the AHRQ-sponsored Keystone Intensive Care Unit Project to reduce infections in Michigan hospitals by implementing CUSP.

The Keystone Project used a comprehensive approach that included promoting a culture of patient safety; improving communication among ICU staff teams; and using a checklist to promote implementation of practices based on guidelines from the CDC. AHRQ continues to support the nationwide implementation of CUSP through a contract with the Health Research & Educational Trust, an affiliate of the American Hospital Association, by reaching more hospitals and other settings in addition to ICUs and applying the approach to various HAIs. For AHRQ's recently funded HAI projects, go to http://www.ahrq.gov/qual/haify10.htm. For more information on CUSP, go to http://www.ahrq.gov/qual/cusp.htm.

The CUSP implementation activities support the Partnership for Patients, a new national public-private partnership with hospitals, medical groups, consumer groups and employers that will help save lives by preventing millions of injuries and complications in patient care over the next 3 years.HHS has set a goal of decreasing preventable hospital-acquired conditions by 40 percent (compared with 2010 rates) by the end of 2013. Achieving this goal should result in approximately 1.8 million fewer injuries and illnesses to patients, with more than 60,000 lives saved over the next 3 years. By preventing injuries and complications and reducing readmissions, the Partnership for Patients has the potential to save up to $35 billion in health care costs by the end of 2013.

For additional information, see the Partnership for Patients at http://www.HealthCare.gov/center/programs/partnership and the HHS Action Plan to Prevent Healthcare-Associated Infections at http://www.hhs.gov/ash/initiatives/hai/index.html.

Editor's Note: Additional research findings from the Keystone Project are available. One study, "Impact of a Statewide Intensive Care Unit Quality Improvement Initiative on Hospital Mortality and Length of Stay: Retrospective Comparative Analysis," published in the Feb. 1, 2011, issue of the British Medical Journal showed that patients in ICUs participating in Keystone were less likely to die. In "Rates of Pneumonia Dramatically Reduced in Patients on Ventilators in Michigan Intensive Care Units," published in the Feb. 17, 2011, issue of Infection Control and Hospital Epidemiology, researchers demonstrated that hospitals participating in the Keystone project reduced the rate of ventilator-associated pneumonia by more than 70 percent.

SOURCE Agency for Healthcare Research & Quality

© 2011 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.